Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126169441 | 12616944 | 1 | I | 20160328 | 20160803 | 20160803 | PER | JP-LUPIN PHARMACEUTICALS INC.-2016-01356 | LUPIN | SHIMAKAWA S, YOSHIKAWA S, FUKUI M, NOMURA S, TANABE T, TAMAI H. CLINICAL FEATURES OF LONG-TERM LOW-DOSE LEVETIRACETAM TREATMENT FOR EPILEPSY. PEDIATRICS INTERNATIONAL. 2016;58(1):40-44. | 10.00 | YR | F | Y | 0.00000 | 20160801 | MD | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126169441 | 12616944 | 1 | PS | LEVETIRACETAM. | LEVETIRACETAM | 1 | Unknown | UNKNOWN | 78154 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126169441 | 12616944 | 1 | Partial seizures |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126169441 | 12616944 | Somnolence |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |